Ligand validation:3VI4

NAG: 2-acetamido-2-deoxy-beta-D-glucopyranose

NAG is a Ligand Of Interest in 3VI4 designated by the RCSB

	Best-fitted instance in this entry
	Other instances in this entry

	Best-fitted instance in this entry
	Best-fitted PDB instances with same target (top 5)

	Best-fitted instance in this entry
	Best-fitted PDB instances with different target (top 5)

Identifier	Ranking for goodness of fit	Ranking for geometry	Real space R factor	Real space correlation coefficient	RMSZ-bond-length	RMSZ-bond-angle	Outliers of bond length	Outliers of bond angle	Atomic clashes	Stereochemical errors	Model completeness	Average occupancy
3VI4_NAG_C_2009	58%	52%	0.143	0.92	0.54	1.28	-	1	0	0	100%	0.9333
3VI4_NAG_A_2007	54%	65%	0.138	0.901	0.5	0.83	-	-	0	0	100%	0.9333
3VI4_NAG_B_504	47%	61%	0.157	0.897	0.47	1.02	-	1	0	0	100%	0.9333
3VI4_NAG_A_2005	43%	58%	0.174	0.899	0.48	1.1	-	1	0	0	100%	0.9333
3VI4_NAG_B_503	40%	58%	0.154	0.864	0.58	1	-	1	0	0	100%	0.9333
3VI4_NAG_D_503	36%	40%	0.136	0.829	0.37	1.93	-	2	0	0	100%	0.9333
3VI4_NAG_A_2016	28%	33%	0.193	0.844	0.51	2.09	-	1	0	0	100%	0.9333
3VI4_NAG_A_2006	22%	57%	0.162	0.775	0.58	1.07	-	1	0	0	100%	0.9333
3VI4_NAG_C_2016	20%	52%	0.192	0.796	0.45	1.39	-	1	1	0	100%	0.9333
3VI4_NAG_C_2008	18%	61%	0.179	0.765	0.54	0.95	-	1	0	0	100%	0.9333
3VI4_NAG_C_2007	14%	64%	0.179	0.733	0.53	0.85	-	1	0	0	100%	0.9333
3VI3_NAG_D_2004	70%	57%	0.097	0.913	0.48	1.16	-	1	0	0	100%	0.9333
1OC7_NAG_A_500	100%	60%	0.04	0.991	0.61	0.9	-	1	0	0	100%	0.9333
1OC6_NAG_A_500	100%	67%	0.041	0.988	0.46	0.8	-	1	0	0	100%	0.9333
1UWC_NAG_A_262	100%	54%	0.046	0.99	0.83	0.93	-	-	0	0	100%	0.9333
6ZE6_NAG_B_703	100%	52%	0.044	0.984	0.78	1.07	-	2	0	0	100%	0.8667
6ZE2_NAG_B_704	99%	56%	0.042	0.979	0.73	0.95	-	1	0	0	100%	0.9333

RCSB PDB Core Operations are funded by the U.S. National Science Foundation (DBI-2321666), the US Department of Energy (DE-SC0019749), and the National Cancer Institute, National Institute of Allergy and Infectious Diseases, and National Institute of General Medical Sciences of the National Institutes of Health under grant R01GM133198.